14-day Premium Trial Subscription Try For FreeGet Free
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of NBIX
Powered by GPT-4
Stock Analysis
Risk Assessment
Trading Strategy

Green day on Monday for Neurocrine Biosciences
(Updated on Nov 27, 2023)

Hold candidate since Nov 17, 2023 Gain 3.75% PDF
The Neurocrine Biosciences stock price gained 0.758% on the last trading day (Monday, 27th Nov 2023), rising from $112.17 to $113.02. It has now gained 6 days in a row. It is not often that stocks manage to gain so many days in a row, and falls for a day or two should be expected. During the last trading day the stock fluctuated 2.45% from a day low at $110.52 to a day high of $113.23. The price has risen in 8 of the last 10 days and is up by 5.46% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 504 thousand more shares were traded than the day before. In total, 724 thousand shares were bought and sold for approximately $81.87 million.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

The stock is moving within a wide and horizontal trend and further movements within this trend can be expected. Given the current horizontal trend, you can expect Neurocrine Biosciences stock with a 90% probability to be traded between $105.63 and $116.44 at the end of this 3-month period. A break of a horizontal trend is often followed by a large increase in the volume, and stocks seldom manage to go directly from the bottom of a trend up to the top. Stocks turning up in the middle of a horizontal trend are therefore considered to be potential runners.

NBIX Signals & Forecast

The Neurocrine Biosciences stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock, but the stock has a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections down, there will be some support from the lines at $110.42 and $111.23. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Friday, November 10, 2023, and so far it has risen 5.46%. Further rise is indicated until a new top pivot has been found. Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).

Special Signal Notification

Double Top Formation

Double Top Formation A sell signal from a double top formation was found on Tuesday, November 07, 2023 and based on theory for this formation the price should fall by -2.96% to $109.67 within 40 trading days since signal was issued (Tuesday, November 28, 2023).

Get your hands on a piece of history – invest in multi-million dollar paintings from $10k with Masterworks.

Support, Risk & Stop-loss for Neurocrine Biosciences stock

Neurocrine Biosciences finds support from accumulated volume at $112.45 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock is usually traded at a good volume, and with minor daily changes, the risk is considered to be low. During the last day, the stock moved $2.71 (2.45%) between high and low. For the last week, the stock has had daily average volatility of 2.00%.

Since the Neurocrine Biosciences has been rising for 6 days in a row, the risk over the next couple of days has increased. As we cannot be certain with regards to the size of the reaction, we urge caution.

Our recommended stop-loss: $107.43 (-4.95%) (This stock has low daily movements and this gives low risk. There is a buy signal from a pivot bottom found 10 days ago.)

Trading Expectations (NBIX) For The Upcoming Trading Day Of Tuesday 28th

For the upcoming trading day on Tuesday, 28th we expect Neurocrine Biosciences to open at $112.26, and during the day (based on 14 day Average True Range), to move between $110.21 and $115.83, which gives a possible trading interval of +/-$2.81 (+/-2.48%) up or down from last closing price. If Neurocrine Biosciences takes out the full calculated possible swing range there will be an estimated 4.97% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $112.45 (0.50%) than the resistance at $115.30 (2.02%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Neurocrine Biosciences stock A Buy?

Neurocrine Biosciences holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

Current score: 0.673 Open Broker Account

Hold/Accumulate Unchanged

Predicted Opening Price for Neurocrine Biosciences of Tuesday, November 28, 2023

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Fair opening price November 28, 2023 Current price
$112.26 $113.02 (Overvalued)

Remember To Visit Our YouTube Channel

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 114.97 1.72 %
R2 113.93 0.81 %
R1 113.29 0.241 %
Current price: 113.02
Support S1 111.22 -1.59 %
S2 110.58 -2.16 %
S3 109.55 -3.07 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 117.10 3.61 %
R2 116.68 3.24 %
R1 115.30 2.02 %
Current price 113.02
Support S1 112.45 -0.504%
S2 110.94 -1.84%
S3 107.17 -5.18%
What is the symbol for Neurocrine Biosciences Stock and on which exchange is it traded?
The symbol for Neurocrine Biosciences is NBIX and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Neurocrine Biosciences Stock?
Neurocrine Biosciences holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

How to buy Neurocrine Biosciences Stock?
Neurocrine Biosciences Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Neurocrine Biosciences Stock.

What's the current price of Neurocrine Biosciences Stock?
As of the end of day on the 2023-11-27, the price of an Neurocrine Biosciences (NBIX) share was $113.02.

What is the 52-week high and low for Neurocrine Biosciences Stock?
The 52-week high for Neurocrine Biosciences Stock is $129.29 and the 52-week low is $89.04.

What is the market capitalization of Neurocrine Biosciences Stock?
As of the 2023-11-27, the market capitalization of Neurocrine Biosciences is 11.104B.

When is the next earnings date for Neurocrine Biosciences?
The upcoming earnings date for Neurocrine Biosciences is 2024-02-05 00:00:00.

Click to get the best stock tips daily for free!

About Neurocrine Biosciences

Neurocrine Biosciences Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, a VMAT2 inhibitor for the treatment of tardive dyskinesia. The company's commercial products include ON... NBIX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE